Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- High-concentration Morphine HCl Preparations to Be Launched by 5 Companies
July 23, 2001
- Pharmacia to Launch Nicorette as OTC Drug in Fall
July 23, 2001
- Shionogi Grants the Rights to BNP Assay to Bayer Corp.
July 23, 2001
- Tsuruha: Sales Up 19.5%, Net Profits Up 8.2%
July 23, 2001
- Oriental Yeast Expands Collaboration with Lexicon Genetics
July 23, 2001
- SSP Wants to Become No. 1 OTC Drug Maker
July 23, 2001
- Suzuken Aims to Become No.1 Wholesaler in 2010
July 23, 2001
- Boots-MC to Be Dissolved
July 23, 2001
- Mochida Licenses Immune Response Modifier from 3M
July 23, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
July 23, 2001
- Taisho, GSK to Jointly Develop Smoking Cessation Aid
July 23, 2001
- Enhancing Competitiveness of Japanese Makers Discussed: OPIR Report
July 23, 2001
- Concomitant HD, CAPD Effective for Chronic Renal Failure: Terumo Seminar
July 23, 2001
- Reports of Medical Device Malfunctions Increasing
July 23, 2001
- REGULATORY NEWS IN BRIEF
July 23, 2001
- Aventis Obtains World Rights to New Cancer Agent from Ajinomoto
July 23, 2001
- NBI's Sales Up 28% to 790 Million Euro in 2000: Prof. Krebs of Boehringer Ingelheim
July 23, 2001
- Int'l Standards of Efficacy, Safety Cross National Boundaries: Korosho Official
July 23, 2001
- Fujisawa Obtains Rights to New Immunosuppressants from Aventis
July 23, 2001
- WORLD NEWS IN BRIEF
July 23, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…